Financial Data and Key Metrics Changes - The company reported a solid start to fiscal Q1 2026, with results modestly ahead of expectations, driven by strength in North America offsetting softness in international markets [8][10] - Organic net sales decreased by 50 basis points, with North America showing growth while international markets faced declines due to product development phasing [10][22] - Adjusted EPS was reported at a loss of $0.03, and adjusted EBITDA was $38 million, both better than the outlook [22] Business Line Data and Key Metrics Changes - Organic net sales in Wet Shave declined approximately 4%, while sun and skincare organic net sales increased by approximately 8%, with sun care growing nearly 20% [22][24] - Grooming organic net sales growth was approximately 7%, led by significant growth in Cremo and Bulldog, while Wet Ones saw a decline of about 15% [24][25] - North America organic net sales grew just under 1%, driven by sun care and grooming, while international markets showed double-digit growth in Oceania and Greater China [22][23] Market Data and Key Metrics Changes - In the U.S., market share declined by 100 basis points overall, but branded volume share increased by 50 basis points, indicating some resilience in brand performance [23][24] - Outside the U.S., share gains were noted in key markets including Australia, Europe, Canada, and China, with over 70% of markets either growing or holding market share [11][12] Company Strategy and Development Direction - The divestiture of the feminine care business is seen as a pivotal step in the company's transformation, allowing for a sharper focus on core categories like shave, sun, skincare, and grooming [9][10] - The company aims to drive sustainable growth and stronger margins by reallocating capital and resources towards these core businesses [9][10] - The strategy includes a focus on international growth, innovation, productivity, and U.S. transformation, with plans for increased brand investment and improved distribution [12][18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to organic net sales growth, driven by mid-single-digit growth in international markets and a more stable performance in North America [19][20] - The company anticipates gross margin expansion supported by productivity gains, despite facing inflationary pressures and tariff impacts [20][21] - Management remains focused on disciplined capital allocation, prioritizing free cash flow generation and debt reduction following the divestiture [35][36] Other Important Information - The company declared a quarterly dividend of $0.15 per share, returning approximately $7 million to shareholders [28] - Adjusted free cash flow is expected to be in the range of $80 million to $110 million for the year, driven by working capital improvements [35] Q&A Session Summary Question: Thoughts on portfolio construction post-Fem Care divestiture - Management highlighted the strategic move to divest the Fem Care business, which was growth dilutive and capital intensive, allowing for a more focused approach on core categories [39][40] Question: Expectations for fiscal Q2 organic sales - Management expects organic net sales to be down about 3% in Q2, with timing shifts affecting performance, but remains confident in achieving the full-year outlook [50][51] Question: Implications of Fem Care dilution into fiscal 2027 - Management discussed the transitional services agreement with Essity and the need to address stranded costs, indicating a stronger portfolio and improved cash flow recovery in fiscal 2027 [53][58] Question: Organic sales phasing and category growth expectations - Management confirmed that category growth rates remain relevant, with expectations for improved performance in the second half of the year driven by better distribution and innovation [64][66]

Core Insights - Kimberly-Clark Corporation reported a stronger-than-expected quarter, driven by solid execution and expanding profit momentum despite sales pressure from changes in the U.S. diaper business [1][3] Financial Performance - The company reported fourth-quarter adjusted earnings per share of $1.86, exceeding the analyst consensus estimate of $1.81 [3] - Quarterly sales were $4.08 billion, slightly missing the expected $4.09 billion, with revenues down by 0.6% and organic sales growth of 2.1% [3] - Gross margin was 35.9%, with an adjusted gross margin of 37%, consistent with the prior year [4] - Adjusted operating profit increased to $629 million, a rise of 13.1% from the previous year, attributed to strong productivity gains and reduced planned spending [4] Strategic Initiatives - The company is making significant progress in various international markets, including Australia, Brazil, and South Korea [5] - The acquisition of Kenvue is viewed as a transformative step that will enhance the company's momentum and improve care standards globally [5] Cash and Dividend - Kimberly-Clark ended the quarter with cash and equivalents totaling $688 million and inventories of $1.475 billion [6] - The company announced an increase in its quarterly dividend to $1.28 per share, up from $1.26, payable on April 2, 2026 [7] 2026 Outlook - The company anticipates reported net sales to be impacted by approximately a 50-basis-point decline due to exiting the U.S. private-label diaper business [8] - Forecasts indicate mid- to high-single-digit adjusted operating profit growth on a constant-currency basis [8] - Expected double-digit adjusted EPS growth from continuing operations is projected, driven by increased equity-company income and stable net interest expense [9]

Core Viewpoint - Kimberly-Clark Corporation (NYSE:KMB) is experiencing a reduction in sales projections due to pantry loading and marketing delays, but maintains a strong position in the market with a low beta stock that can outperform during market volatility [1][2]. Group 1: Sales and Earnings Projections - Evercore ISI has lowered its third-quarter sales projections for Kimberly-Clark to about 1%, which is two percentage points below consensus predictions [1]. - Despite the lower sales expectations, Evercore ISI has maintained its earnings per share estimates, attributing this to pulp deflation and cost reductions [2]. Group 2: Company Overview - Kimberly-Clark Corporation is a major American manufacturer specializing in personal care and hygiene products, operating through three primary business segments: Personal Care, Consumer Tissue, and K-C Professional [3]. - The company markets its products under well-known brand names such as Kleenex, Scott, Cottonelle, DryNites, and Huggies [3]. Group 3: Investment Considerations - The current stock price of Kimberly-Clark is viewed as a viable entry point, especially during regression-to-the-mean trading periods [2].

Core Insights - Kimberly-Clark Corp. is set to report its Q3 2025 earnings on October 21, with analysts expecting an EPS of $1.72, a decrease from $1.83 in the same period last year [2] - The company reported Q2 2025 earnings on August 1, achieving an adjusted EPS of $1.92, surpassing the analyst consensus of $1.66, although quarterly sales of $4.20 billion fell short of the expected $4.86 billion [4] - The company's dividend yield stands at 4.06%, with total dividends paid per share amounting to $5.04 over the last 12 months [3] Financial Performance - Q3 2025 revenue is projected to be $4.18 billion, down from $4.95 billion year-over-year [2] - In Q2 2025, adjusted gross margin was reported at 36.9%, a decline of 180 basis points from the previous year, attributed to unfavorable pricing and cost inflation [4] - The company anticipates a low-to-mid single-digit growth rate in adjusted operating profit and adjusted EPS for 2025 on a constant-currency basis compared to the prior year [5] Investment Insights - To generate an income of $100 per month from Kimberly-Clark dividends, an investment of approximately $29,557 is required, based on the current dividend yield [6][7] - The stock price has fluctuated within a 52-week range of $123.80 to $150.45 [3]

Group 1 - Kimberly-Clark will release its second quarter 2025 results on August 1, 2025, at approximately 6:30 a.m. EDT [1] - A live Q&A session with analysts will follow the earnings release, starting at 8:00 a.m. EDT [1] - The earnings release and supplemental materials will be accessible through Kimberly-Clark's Investor Relations website, along with a replay of the webcast [2] Group 2 - Kimberly-Clark operates in over 175 countries and territories, providing essential products under trusted brands [3] - The company's portfolio includes well-known brands such as Huggies, Kleenex, and Scott, which hold No. 1 or No. 2 market share positions in approximately 70 countries [3] - Kimberly-Clark has been recognized as one of the World's Most Ethical Companies® for seven consecutive years and was listed among Fortune's Most Innovative Companies in America in 2024 [3]

Core Insights - Procter & Gamble (PG) is implementing a significant supply chain overhaul to enhance operational resilience and adapt to market changes, indicating a potential transformation in the consumer staples sector [1][4] Supply Chain Strategy - PG anticipates an annualized cost impact of $1–1.5 billion due to tariffs affecting raw materials, packaging, and finished goods from China, prompting the company to enhance productivity and explore pricing adjustments and sourcing changes [2][9] - The company's strategy emphasizes end-to-end digitization, regionalization of production, and agility, with investments in advanced analytics, real-time inventory tracking, and AI-powered forecasting to improve responsiveness and reduce waste [3][9] Competitive Landscape - Competitors Kimberly-Clark (KMB) and Colgate-Palmolive (CL) are also advancing their supply chain strategies, focusing on nearshoring, real-time inventory optimization, and AI-driven demand forecasting to enhance resilience and agility [5][6][7] Financial Performance - PG's stock has declined approximately 3.9% over the past three months, compared to a 1.6% decline in the industry [8] - The company trades at a forward price-to-earnings ratio of 23.17X, above the industry average of 20.77X, indicating a premium valuation [10] - The Zacks Consensus Estimate projects year-over-year earnings growth of 2.9% for fiscal 2025 and 3.5% for fiscal 2026, with recent estimates remaining unchanged [11]